Whilst mutations in genes encoding Rho GTPases are rare in cancer, somatic mutations have been reported in RHOA, RHOB, RAC1, RAC2, and CDC42 (Hurst et al., 2017; Aspenström, 2018). Here, RHOA is linked to cancer.